Saturday 17 October 2026
Export AEMD’s income statement to Excel — free account
Aethlon Medical, Inc.
AEMD Healthcare Medical Devices
Aethlon Medical, Inc.’s revenue for fiscal 2023 (year ended March 2023) was $574,200.00, up 95.2% from fiscal 2022. In the quarter to June 2026, EPS grew 90.5% and free cash flow fell 11.1%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
5.15
0.12
−2.28%
Follow AEMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.76 | 3.47 | 5.53 | 4.32 | |
Current Ratio |
5.42 | 3.85 | 5.68 | 4.45 | |
Net Debt/EBITDA |
3.45 | 2.43 | 3.65 | 4.31 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.23 | 0.93 | 0.93 | 1.12 | |
Capex/Depreciation |
(0.06) | 0.01 | (0.01) | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.93) | (12.99) | (11.39) | (20.87) | |
Capex per Share |
(0.02) | (0.01) | (0.01) | 0.00 | |
Free Cash Flow per Share |
(4.95) | (13.00) | (11.40) | (20.87) | |
Cash per Share |
12.82 | 37.29 | 42.26 | 73.63 | |
Shareholders Equity per Share |
13.52 | 36.25 | 40.78 | 72.28 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
13.52 | 36.25 | 40.78 | 72.28 | |
Free Cash Flow |
(1.91) | (1.75) | (1.88) | (1.66) | |
Working Capital |
4.57 | 4.12 | 5.88 | 4.85 | |
Capital Expenditures |
(0.01) | 0.00 | 0.00 | — | |
Net Current Asset Value |
4.57 | 4.12 | 5.80 | 4.68 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
| Other line items | |||||
Average Receivables |
— | — | — | 0.18 | |
Average Payables |
0.49 | 0.46 | 0.54 | 0.75 | |
Average Assets |
5.77 | 6.85 | 7.29 | 8.09 | |
Average Common Equity |
4.31 | 5.00 | 5.52 | 5.88 |
Columns are period end dates